KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary

Bertram L. Kasiske, Martin G. Zeier, Jeremy R. Chapman, Jonathan C. Craig, Henrik Ekberg, Catherine A. Garvey, Michael D. Green, Vivekanand Jha, Michelle A. Josephson, Bryce A. Kiberd, Henri A. Kreis, Ruth A. McDonald, John M. Newmann, Gregorio T. Obrador, Flavio G. Vincenti, Michael Cheung, Amy Earley, Gowri Raman, Samuel Abariga, Martin WagnerEthan M. Balk

Research output: Contribution to journalReview articlepeer-review

562 Scopus citations


The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on the monitoring, management, and treatment of kidney transplant recipients is intended to assist the practitioner caring for adults and children after kidney transplantation. The guideline development process followed an evidence-based approach, and management recommendations are based on systematic reviews of relevant treatment trials. Critical appraisal of the quality of the evidence and the strength of recommendations followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. The guideline makes recommendations for immunosuppression and graft monitoring, as well as prevention and treatment of infection, cardiovascular disease, malignancy, and other complications that are common in kidney transplant recipients, including hematological and bone disorders. Limitations of the evidence, especially the lack of definitive clinical outcome trials, are discussed and suggestions are provided for future research. This summary includes a brief description of methodology and the complete guideline recommendations but does not include the rationale and references for each recommendation, which are published elsewhere.

Original languageEnglish (US)
Pages (from-to)299-311
Number of pages13
JournalKidney international
Issue number4
StatePublished - Feb 2010

Bibliographical note

Funding Information:
KDIGO gratefully acknowledges the following sponsors that make our initiatives possible: Abbott, Amgen, Belo Foundation, Coca-Cola Company, Dole Food Company, Genzyme, Hoffmann-LaRoche, JC Penney, NATCO—The Organization for Transplant Professionals, National Kidney Foundation—Board of Directors, Novartis, Robert and Jane Cizik Foundation, Shire, Transwestern Commercial Services, and Wyeth. KDIGO is supported by a consortium of sponsors and no funding is accepted for the development of specific guidelines.


  • Disease management
  • Kidney transplantation
  • Practice guideline
  • Systematic review


Dive into the research topics of 'KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary'. Together they form a unique fingerprint.

Cite this